Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28408061 | 0.98 | SIRT2 (0.32) | SIRT2 | |
| SCHEMBL3058860 | 0.98 | SIRT2 (0.32) | SIRT2 | |
| SCHEMBL8813475 | 0.98 | SIRT2 (0.32) | SIRT2 | |
| SCHEMBL29024225 | 0.98 | SIRT2 (0.32) | SIRT2 | |
| SCHEMBL408490 | 0.98 | SIRT2 (0.32) | SIRT2 | |
| SCHEMBL3248123 | 0.98 | SIRT2 (0.32) | SIRT2 | |
| SCHEMBL28994499 | 0.98 | SIRT2 (0.32) | SIRT2 | |
| SCHEMBL28391020 | 0.97 | SIRT2 (0.31) | SIRT2 | |
| SCHEMBL28133293 | 0.91 | — | — | |
| SCHEMBL6679396 | 0.83 | TSHR (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008090489-A2 | COSMETIC SKINCARE USE OF IRON GLUCONATE COMBINATIONS | L'OREAL (FR) | 2008-07-31 | — | — | WO | disclosed |
| US-20080008670-A1 | Process for colouring dark skin | L'OREAL (FR) | 2008-01-10 | — | — | US | disclosed |
| US-20070081954-A1 | Dispersion of polymer particles, composition comprising it and cosmetic treatment method | L'OREAL S.A. (FR) | 2007-04-12 | — | — | US | disclosed |
| EP-1133979-B1 | Use of specific fatty compounds for modifying the physico-chemical properties of the skin and/or the mucous membrane as agents for preventing or reducing the adhesion of micro-organisms thereon | OREAL (FR) | 2005-10-26 | — | — | EP | disclosed |
| EP-1133979-A2 | Use of specific fatty compounds for modifying the physico-chemical properties of the skin and/or the mucous membrane as agents for preventing or reducing the adhesion of micro-organisms thereon | L'OREAL (FR) | 2001-09-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080008670-A1 | Process for colouring dark skin | CUTA, DSG1, TYR | SIRT2 4719/4885 |
| US-20070081954-A1 | Dispersion of polymer particles, composition comprising it and cosmetic treatment method | KRT18, KRTCAP2, KIF18B | SIRT2 2544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.